Multicentric, Prospective, Non-interventional, Long-term Cohort Study in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

To assess the importance of intracellular signalling pathways and its deregulation in adiposity and diabetes-related insulin resistance, liver tissue samples of patients suffering from non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)will be analyzed prospectively from a liver tissue bank.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients with histologically confirmed fatty liver disease

Locations
Other Locations
Switzerland
University Hospital Zurich, Endocrinology and Diabetology
RECRUITING
Zurich
Contact Information
Primary
Oliver Tschopp
oliver.tschopp@usz.ch
+41 (0)44 255 11 11
Backup
Giatgen Spinas, Professor, MD
giatgen.spinas@usz.ch
Time Frame
Start Date: 2007-12
Estimated Completion Date: 2027-11
Participants
Target number of participants: 150
Related Therapeutic Areas
Sponsors
Leads: University of Zurich

This content was sourced from clinicaltrials.gov